Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of fibrinopeptide b, human in China, also supports custom service. Welcome to wholesale bulk high quality fibrinopeptide b, human from our factory. Contact us for more details.
| Description | Fibrinopeptide B, human (CAS: 36204-23-6) is the 14-residue short peptide released from the N-terminus of the human fibrinogen beta chain by thrombin, sequence {Glp}-Gly-Val-Asn-Asp-Asn-Glu-Glu-Gly-Phe-Phe-Ser-Ala-Arg with an N-terminal pyroglutamic acid cap. Molecular formula C66H93N19O25, MW 1552.56 Da. Thrombin first releases fibrinopeptide A and then fibrinopeptide B; the sequential release is essential for fibrinogen-to-fibrin conversion and normal fibrin polymerization. FPB is strongly acidic and interacts with fibrinogen binding sites; its generation rate reflects thrombin activity, and it is a standard peptide for coagulation cascade studies, thrombotic-disease marker assays, and anticoagulant activity evaluation. |
| Structure type | Linear 14-mer (N-terminal pyroglutamyl human fibrinogen beta-chain thrombin-released peptide) |
| Solubility | Readily soluble in water, PBS buffer |
| Storage | Powder -20C, dry, protected from light |
Product Basic Information Table
| Product Standard English Name | Product Abbreviation / Alias | Function Tags (comma-separated) | Core Structure | Molecular Formula | Exact Mass (Da) | Average MW (Da) | Salt Form | Length (aa) |
| Fibrinopeptide B, human (14-aa peptide released by thrombin from the N-terminus of fibrinogen Bβ chain, N-terminal pyroglutamate) | FpB; Fibrinopeptide B; Bβ1-14; pGlu-Gly-Val-Asn-Asp-Asn-Glu-Glu-Gly-Phe-Phe-Ser-Ala-Arg-OH; pEGVNDNEEGFFSAR-OH; Glp-GVNDNEEGFFSAR; CAS 36204-23-6 | coagulation biomarker, fibrinopeptide, thrombin substrate, fibrinolysis research, thrombosis research, pyroglutamylated, acidic peptide, free acid, water-soluble | Linear 14-aa acidic short peptide, sequence pGlu-Gly-Val-Asn-Asp-Asn-Glu-Glu-Gly-Phe-Phe-Ser-Ala-Arg-OH (pEGVNDNEEGFFSAR-OH; residues Bβ1-14 of fibrinogen); the N-terminal Gln cyclizes to pyroglutamate (pGlu/Glp), with no free N-terminal amino group and no C-terminal amidation (free acid); side-chain net charge ~-3 (1 Arg positive, 1 Asp + 2 Glu negative; pGlu contributes no amino charge); contains two consecutive Phe (Phe10-Phe11) as the main hydrophobic residues, hydrophobic fraction ~29%; contains 2 Asn (potential deamidation sites); no Cys/Met/Trp (no disulfide/oxidation/photo-oxidation); rich in acidic residues with low pI and good aqueous solubility; same Bβ1-14 sequence as [Glu1]-FpB (PEP-EFPB-01) but in the native pyroglutamylated N-terminal form (vs. the free-Glu linear analog) | C66H93N19O25 | 1551.66 | 1552.58 | Free acid (C-terminal -COOH); no counterion salt; powder | 14 |
Physicochemical Solubility & Storage Parameters
| Product Code | Appearance | Long-term Storage | Short-term Storage | Solution Stability | Solid Powder Stability |
| PEP-FPBH-01 | White to off-white powder | Store at -20°C, sealed, desiccated, protected from light (~2 years). Aliquot to avoid repeated freeze-thaw. No Met/Cys/Trp-low oxidation/photo-oxidation risk; Asn residues may slowly deamidate on long storage or repeated freeze-thaw, so keep dry, cold, and avoid freeze-thaw. | 2–8°C for up to ~1 month; working aliquots at -20°C; stable for shipping at ambient. | Acidic short peptide with good water solubility (soluble to several mg/mL in aqueous buffers); the two Phe residues add slight hydrophobicity-use dilute acetic acid or mild sonication if needed. No Cys (no disulfide), no Met (no oxidation), no Trp (no photo-oxidation); avoid heat and alkaline conditions for Asn deamidation. The lyophilate is hygroscopic-weigh quickly and reseal. | solid stable for ~2 years at -20°C, sealed and desiccated; keep the desiccator sealed and the weighing environment dry. |
Functional Description
| Product Code | Frontend Short Summary | Detailed Biological Function Description | Applicable Research Areas (comma-separated) | Targets / Pathways |
| PEP-FPBH-01 | The 14-aa peptide (N-terminal pyroglutamate) released by thrombin from the N-terminus of fibrinogen Bβ chain-a classic circulating marker of thrombin activation and fibrin formation, used in coagulation/fibrinolysis/thrombosis research. | Human fibrinopeptide B (FpB) is the 14-aa peptide (Bβ1-14) released when thrombin cleaves the N-terminus of the fibrinogen Bβ chain at the Arg14-Gly15 bond, released together with fibrinopeptide A (FPA, Aα1-16). FpB release is generally slower than FPA: FPA release drives longitudinal polymerization of fibrin monomers, whereas FpB release further exposes the Bβ-chain Gly-His-Arg-Pro (GHRP) polymerization site, promoting lateral aggregation of protofibrils into thick, branched fibrin fibers; FpB release accelerates as polymerization proceeds. Plasma/serum FpB (and its ratio to FPA) is a direct marker of in-vivo thrombin generation and coagulation-system activation, measured in DIC, deep-vein thrombosis, myocardial infarction, sepsis-associated coagulopathy and hypercoagulable states. The N-terminal Gln cyclizes to pyroglutamate, resisting N-terminal carbamylation and stabilizing the peptide in circulation. This synthetic free-acid standard is used for calibration curves, antibody development, thrombin activity assays and studies of fibrin polymerization. | Coagulation & hemostasis, thrombosis, DIC, fibrinolysis research, fibrin polymerization mechanism, thrombin substrate/activity assays, biomarker detection | Fibrinogen Bβ-chain N-terminus (thrombin cleavage site Arg14-Gly15); marker of in-vivo thrombin generation; fibrin lateral aggregation (GHRP polymerization site exposure) |
Hot Tags: fibrinopeptide b, human, China fibrinopeptide b, human manufacturers, suppliers, factory, 239075-62-8, 400090-20-2, 93675-01-5, CAS 93674 95 4, cell adhesion peptides, GRGDSPC
